1. Home
  2. ZLAB vs NTB Comparison

ZLAB vs NTB Comparison

Compare ZLAB & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$19.77

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Bank of N.T. Butterfield & Son Limited (The) Voting

NTB

Bank of N.T. Butterfield & Son Limited (The) Voting

HOLD

Current Price

$59.40

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
NTB
Founded
2013
1858
Country
China
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
ZLAB
NTB
Price
$19.77
$59.40
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$49.60
$53.75
AVG Volume (30 Days)
888.8K
214.6K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
3.66%
EPS Growth
38.46
N/A
EPS
N/A
N/A
Revenue
$460,156,000.00
N/A
Revenue This Year
$9.75
$0.84
Revenue Next Year
$26.03
$4.16
P/E Ratio
N/A
$9.64
Revenue Growth
15.33
N/A
52 Week Low
$15.96
$40.59
52 Week High
$41.20
$61.11

Technical Indicators

Market Signals
Indicator
ZLAB
NTB
Relative Strength Index (RSI) 62.65 54.59
Support Level $19.51 $57.71
Resistance Level $20.25 N/A
Average True Range (ATR) 0.75 1.02
MACD 0.24 -0.01
Stochastic Oscillator 99.24 51.69

Price Performance

Historical Comparison
ZLAB
NTB

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.

Share on Social Networks: